Moderna Balance Sheet
NASDAQ: MRNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Moderna financial position
At the end of fiscal 2025, Moderna reported total assets of $12.34 billion, down 12.8% from a year earlier against total liabilities of $3.69 billion. Shareholders' equity stood at $8.65 billion, or 70.1% of assets. The company held $2.60 billion in cash and equivalents against $590.0 million of debt, a net cash position of $2.00 billion.
The current ratio (current assets divided by current liabilities) was 3.29, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.07.
Summary generated from market data by MetaCap's automated system. Methodology
Moderna balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.60B | 1.93B | 2.91B | 3.21B | 6.85B | 2.62B | 236.00M | 658.36M | 134.86M | 50.08M |
| Short-Term Investments | 3.20B | 5.10B | 5.70B | 6.70B | 3.88B | 1.98B | 867.12M | 863.06M | 621.17M | — |
| Receivables | 184.00M | 358.00M | 892.00M | 1.39B | 3.17B | 1.39B | 5.37M | 11.69M | 11.88M | — |
| Inventory | 153.00M | 117.00M | 202.00M | 949.00M | 1.44B | 47.00M | 0 | — | — | — |
| Total Current Assets | 6.54B | 8.10B | 10.32B | 13.43B | 16.07B | 6.30B | 1.13B | 1.56B | 783.22M | — |
| Property, Plant & Equipment | 2.13B | 2.20B | 1.95B | 2.02B | 1.24B | 297.00M | 201.50M | 211.98M | 139.03M | — |
| Goodwill | 52.00M | 52.00M | 52.00M | 0 | — | — | — | — | — | — |
| Intangible Assets | 45.00M | 40.00M | 44.00M | 0 | — | — | — | — | — | — |
| Long-Term Investments | 2.34B | 2.49B | 4.68B | 8.32B | 6.84B | 639.00M | 159.99M | 172.99M | 145.85M | — |
| Total Assets | 12.34B | 14.14B | 18.43B | 25.86B | 24.67B | 7.34B | 1.59B | 1.96B | 1.08B | — |
| Accounts Payable | 317.00M | 405.00M | 520.00M | 487.00M | 302.00M | 18.00M | 7.09M | 31.21M | 20.73M | — |
| Total Current Liabilities | 1.99B | 2.21B | 3.02B | 4.92B | 9.13B | 4.39B | 143.12M | 222.80M | 191.46M | — |
| Long-Term Debt | 590.00M | 0 | — | — | — | — | — | — | — | — |
| Total Liabilities | 3.69B | 3.24B | 4.57B | 6.74B | 10.52B | 4.78B | 414.61M | 431.91M | 459.19M | — |
| Shareholders' Equity | 8.65B | 10.90B | 13.85B | 19.12B | 14.14B | 2.56B | 1.18B | 1.53B | -551.37M | -334.81M |
| Retained Earnings | 7.22B | 10.04B | 13.61B | 18.32B | 9.96B | -2.24B | -1.50B | -1.01B | -621.89M | — |
| Total Debt | 590.00M | 0 | — | — | — | — | — | — | — | — |
| Net Cash (Debt) | 5.21B | 7.03B | 8.60B | 9.90B | 10.73B | 4.61B | 1.10B | 1.52B | 756.03M | 50.08M |
| Shares Outstanding | 394.00M | 386.00M | 382.00M | 385.00M | 403.00M | 399.00M | 336.54M | 328.80M | 65.21M | — |
This table shows 10 annual periods of Moderna's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MRNA's reporting calendar. What is a balance sheet?